Abilify Gambling Addiction Litigation Attorneys
West Palm Beach and Palm Beach County
Abilify (Abilify Maintena and Aristada), manufactured by Otsuka Pharmaceutical Co. 
and Bristol-Myers Squibb Company, is an Antipsychotic drug marketed to treat schizophrenia, bipolar disorder, depression, and Tourette syndrome. It is also marketed to treat irritability associated with autism.
Claims against Abilify are that the drug was negligently manufactured and designed, and the drug maker failed to provide adequate instructions and warnings of its risk to the public. The major claim against the manufacturers is that they knew of the alleged tendency for causing compulsive behaviors.
These behaviors included compulsive gambling, compulsive spending, compulsive eating, hypersexuality, and stealing or shoplifting. Other side effects included anxiety, fatigue, dizziness, headaches, insomnia, high blood sugar, and suicidal tenancies. Some patients of the drug experienced extreme debt, home loss, permanent disability, and even death.
In 2005, The U.S. Food and Drug Administration (FDA) issued a public health advisory about certain drugs (Abilify, Seroquel, Risperdal, and others) used to treat behavioral problems in elderly patients with dementia. The FDA ordered Abilify to add warning labels as more deaths were seen with elderly patients with dementia.
If you or a loved one suffered compulsive behaviors after taking Abilify, you may be entitled to compensation. Please call our Defect Drug Lawyers or contact us here for a free consultation.
Please note that in some matters, we may co-counsel or refer the case to another lawyer or law firm.
